NMN (Nicotinamide Mononucleotide) sourcing in 2026.
NMN is the highest-stakes ingredient on the EU sourcing roadmap right now. As of 2026 it remains in regulatory limbo: classified by EFSA as requiring novel food authorisation, with the file submitted but not concluded. Sourcing decisions today need to plan for either authorisation or restriction.
Forms on the market
| Form | Notes |
|---|---|
| Standard ≥99% (Chinese fermentation) | Most volume |
| Beta-NMN ≥99.5% (premium) | Validated isomer |
| Stabilised microencapsulated NMN | For better shelf life |
EU pricing and MOQ
- Standard 99% (Chinese): €350–€600/kg, MOQ 5 kg
- Pharma-grade 99.5%+: €800–€1,400/kg, MOQ 1 kg
What to test per batch
- Purity by HPLC ≥99%
- Beta-isomer % (alpha-isomer should be < 1%)
- Heavy metals, residual solvents
- Endotoxin (if positioned as pharma-grade)
- Stability, NMN degrades with heat and humidity
Regulatory in the EU
EFSA novel food file under review in 2026. Several member states (notably France) have taken enforcement action against NMN supplements pending authorisation. UK and US markets remain open under different frameworks. Confirm market-by-market before listing.
Top suppliers
Suzhou Mannova · Shanghai Genshine · Effepharm · Maac10 Formulations
Tell Jake kg/year, form, and target market. He'll intro 2–3 verified suppliers with CoAs and samples.
